HTA
PFE icon

Haber Trilix Advisors’s Pfizer PFE Stock Holding History

Haber Trilix Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$52K Buy
+1,950
New +$53.9K 0.01% 241

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Haber Trilix Advisors's PFE Position: Q2 2013 in Review

Haber Trilix Advisors opened a new position in Pfizer (PFE) in Q2 2013: 1,950 shares worth $52K. The stake represents 0.01% of the portfolio and ranks #241 among its holdings.

1,627 funds tracked by Wall St. Rank hold PFE as of Q2 2013.

  • Haber Trilix Advisors held 1,950 shares of Pfizer worth $52K as of Q2 2013.
  • Pfizer was a new Haber Trilix Advisors position in Q2 2013.
  • Pfizer made up 0.01% of Haber Trilix Advisors's portfolio in Q2 2013, its #241 holding.
  • 1,627 funds tracked by Wall St. Rank held Pfizer as of Q2 2013.

Based on Haber Trilix Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.